Methyltestosterone
Showing 1 - 25 of 231
Polycystic Ovary Syndrome, Hypertension Trial in New Haven (GnRH antagonist, GnRH antagonist + MethylTESTOSTERone 5 MG)
Completed
- Polycystic Ovary Syndrome
- Hypertension
- GnRH antagonist
- GnRH antagonist + MethylTESTOSTERone 5 MG
-
New Haven, ConnecticutThe John B Pierce Laboratory
Dec 8, 2022
Arthroplasty, Replacement, Hip Trial in Des Plaines (Testosterone Therapy, No Testosterone Therapy)
Withdrawn
- Arthroplasty, Replacement, Hip
- Testosterone Therapy
- No Testosterone Therapy
-
Des Plaines, IllinoisAmerican Hip Institute Research Foundation
Feb 1, 2023
Breast Cancer, Breast Carcinoma, Metastatic Breast Cancer Trial in New York (18F-FDG PET/CT, [18F]-Fluoro-2-Deoxy-D-Glucose and
Recruiting
- Breast Cancer
- +4 more
- 18F-FDG PET/CT
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Nov 17, 2023
Stress Urinary Incontinence, Menopause Trial (Testosterone cypionate, Placebo)
Not yet recruiting
- Stress Urinary Incontinence
- Menopause
- Testosterone cypionate
- Placebo
- (no location specified)
Oct 30, 2023
Hypogonadism, Osteopenia, Osteoporosis Trial in Boston (Testosterone, Alendronate, Placebo Alendronate)
Terminated
- Hypogonadism
- +2 more
- Testosterone
- +3 more
-
Boston, MassachusettsMassachusetts General Hospital
Aug 16, 2022
Spinal Cord Injury, Spinal Cord Injuries, Trauma, Nervous System Trial in Tampa, Gainesville (Testosterone Enanthate,
Terminated
- Spinal Cord Injury
- +10 more
- Testosterone Enanthate
- +3 more
-
Tampa, Florida
- +1 more
Jul 28, 2022
Muscle, Fat and Tissue Receptors
Active, not recruiting
- Gender Incongruence
- Transgenderism
- testosterone cypionate
- Estradiol Valerate
-
Saint Louis, MissouriSaint Louis Univeristy
Jan 13, 2023
Aging Trial in Galveston (drug, dietary supplement, other)
Active, not recruiting
- Aging
- Testosterone
- +3 more
-
Galveston, TexasJennie Sealy Hospital
Apr 13, 2022
Hypogonadism, Malignant Urinary System Tumor, Urinary System Disorder Trial in Atlanta (other, procedure, drug)
Recruiting
- Hypogonadism
- +3 more
- Best Practice
- +3 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Jan 3, 2023
Hypoactive Sexual Desire Disorder Trial in San Diego (Oral Testosterone Undecanoate)
Not yet recruiting
- Hypoactive Sexual Desire Disorder
- Oral Testosterone Undecanoate
-
San Diego, CaliforniaSan Diego Sexual Medicine
Oct 12, 2023
Facioscapulohumeral Muscular Dystrophy Trial in Rochester (Testosterone Enanthate, Somatropin)
Completed
- Facioscapulohumeral Muscular Dystrophy
- Testosterone Enanthate
- Somatropin
-
Rochester, New YorkUniversity of Rochester
Jun 7, 2022
Testosterone, Transsexualism, Hematologic Diseases Trial (Testosterone Cypionate 100 MG/ML)
Not yet recruiting
- Testosterone
- +2 more
- Testosterone Cypionate 100 MG/ML
- (no location specified)
Aug 1, 2022
Contraception Trial (etonogestrel with testosterone undecanoate, Placebo)
Completed
- Contraception
- etonogestrel with testosterone undecanoate
- Placebo
- (no location specified)
Feb 2, 2022
Spinal Cord Injury Trial in Bronx (Natesto testosterone intranasal gel, Ayr Saline Nasal Gel)
Not yet recruiting
- Spinal Cord Injury
- Natesto testosterone intranasal gel
- Ayr Saline Nasal Gel
-
Bronx, New YorkJames J. Peters VA Medical Center, Bronx, NY
Nov 8, 2023
Prostate Cancer Trial in Baltimore (DFMO, testosterone cypionate, Luteinizing hormone-releasing hormone (LHRH) analogue)
Not yet recruiting
- Prostate Cancer
- DFMO
- +3 more
-
Baltimore, MarylandJohns Hopkins University: Sidney Kimmel Comprehensive Cancer Cen
Sep 22, 2023
Castration-resistant Prostate Cancer, Homologous Recombination Deficiency Trial in Sydney (Testosterone Enanthate 100 MG/ML
Recruiting
- Castration-resistant Prostate Cancer
- Homologous Recombination Deficiency
- Testosterone Enanthate 100 MG/ML Injectable Solution
- Testosterone Enanthate 100 MG/ML Injectable Solution / Carboplatin AUC 5
-
Sydney, New South Wales, AustraliaKinghorn Cancer Centre, St. Vincent's Hospital
Dec 16, 2022
Castration-Sensitive Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Prostate Carcinoma Trial in Seattle
Active, not recruiting
- Castration-Sensitive Prostate Carcinoma
- +7 more
- Antiandrogen Therapy
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 8, 2022
Metastatic Castration-resistant Prostate Cancer Trial in New Haven (Testosterone Cypionate, Sipuleucel-T)
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer
- Testosterone Cypionate
- Sipuleucel-T
-
New Haven, ConnecticutYale Cancer Center
Oct 20, 2023
Hypogonadism, Male, Fatigue Syndrome, Chronic Trial in Boston, Seattle (Testosterone Undecanoate 750 MG/3 ML Intramuscular
Recruiting
- Hypogonadism, Male
- Fatigue Syndrome, Chronic
- Testosterone Undecanoate 750 MG/3 ML Intramuscular Solution [AVEED]
- placebo
-
Boston, Massachusetts
- +1 more
Aug 11, 2022
Stage IV Prostate Adenocarcinoma AJCC v7 Trial in Worldwide (drug, other, procedure)
Recruiting
- Stage IV Prostate Adenocarcinoma AJCC v7
- Antiandrogen Therapy
- +5 more
-
Duarte, California
- +15 more
Jan 24, 2023
Pain, Opioid Use, Androgen Deficiency Trial in Boston (Testosterone Cypionate, Placebo)
Recruiting
- Pain
- +2 more
- Testosterone Cypionate
- Placebo
-
Boston, MassachusettsBrigham and Women's Hospital
Apr 26, 2022
Erectile Dysfunction, Sexual Dysfunction Trial in Salt Lake City (Natesto Nasal Product, Placebo)
Recruiting
- Erectile Dysfunction
- Sexual Dysfunction
- Natesto Nasal Product
- Placebo
-
Salt Lake City, UtahUniversity of Utah, Division of Urology
Aug 11, 2022
Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8 Trial in Philadelphia
Recruiting
- Prostate Adenocarcinoma
- +2 more
- MRI-guided Intensity-Modulated Radiation Therapy
- +7 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Jan 4, 2023